Which hedge funds own SGRY? SURGERY PARTNERS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
8 of the hedge funds tracked by WhaleCreep disclosed a position in SGRY (SURGERY PARTNERS INC) in their Q2 2026 13F filings, worth $265.8m in total. The largest holder by portfolio weight is Pentwater Capital Management at 1.6% of its book. 1 manager opened a new position this quarter: Renaissance Technologies LLC. 3 exited: Glenview Capital Management, Irenic Capital Management, Millennium Management.
8tracked managers holding
1opened this quarter
3exited this quarter
Which hedge funds hold SGRY? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Pentwater Capital Management | Q2 2026 | 1.6% | $195.4m | 11,630,000 | -8% | reduced |
| Davidson Kempner Capital Management | Q2 2026 | 0.9% | $56.1m | 3,336,464 | 0% | held |
| Moore Capital Management | Q2 2026 | 0.0% | $840.0k | 50,000 | 0% | held |
| Tudor Investment | Q2 2026 | 0.0% | $2.6m | 153,926 | -43% | reduced |
| Holocene Advisors | Q2 2026 | 0.0% | $2.3m | 136,328 | 12% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $2.2m | 130,100 | – | new |
| Citadel Advisors | Q2 2026 | 0.0% | $4.9m | 291,280 | -27% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $1.6m | 95,362 | 644% | added |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Glenview Capital Management | 5.0% | $21.5m |
| Irenic Capital Management | 5.8% | $8.5m |
| Millennium Management | 0.1% | $5.1m |
How has hedge fund ownership of SGRY changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 8 | $265.8m |
| Q1 2026 | 10 | $235.8m |
| Q4 2025 | 5 | $216.9m |
| Q3 2025 | 7 | $358.7m |
| Q2 2025 | 8 | $254.7m |
| Q1 2025 | 7 | $101.5m |
| Q4 2024 | 7 | $71.0m |
| Q3 2024 | 5 | $66.5m |
| Q2 2024 | 7 | $146.1m |
| Q1 2024 | 5 | $206.6m |
| Q4 2023 | 6 | $234.2m |
| Q3 2023 | 6 | $225.4m |
| Q2 2023 | 6 | $410.5m |
| Q1 2023 | 4 | $380.0m |
| Q4 2022 | 5 | $322.5m |
| Q3 2022 | 4 | $79.8m |
Counts every tracked manager that disclosed SGRY in that quarter's filing, including managers that have since stopped filing.